Literature DB >> 10194028

Symptoms, disability, and quality of life in patients with carpal tunnel syndrome.

I Atroshi1, C Gummesson, R Johnsson, A Sprinchorn.   

Abstract

We used validated outcome instruments to measure symptoms, disability, and health-related quality of life in 58 patients with carpal tunnel syndrome (CTS). The patients completed the CTS instrument before and 6 weeks, 3 months, and 6 months after surgery and the Short Form-36 (SF-36) before and 3 months after surgery. The size of clinical change detected by each outcome measure was estimated by the standardized response mean (mean change/ standard deviation of the change). Large improvement was observed for the CTS symptom scale (mean standardized response, 1.4-1.9) and function scale (0.8-1.1). Improvement in SF-36 scales was large for pain (1.0) and moderate for physical role, mental health, and the physical component summary (0.5-0.6). Compared with the general population SF-36 norms (n = 2,181), CTS patients had significantly worse scores for physical functioning, physical role, pain, vitality, and the physical component summary before surgery. After surgery, SF-36 scores had normalized except for physical role and the physical component summary.

Entities:  

Mesh:

Year:  1999        PMID: 10194028     DOI: 10.1016/s0363-5023(99)70014-6

Source DB:  PubMed          Journal:  J Hand Surg Am        ISSN: 0363-5023            Impact factor:   2.230


  29 in total

1.  The role of job strain on return to work after carpal tunnel surgery.

Authors:  D Gimeno; B C Amick; R V Habeck; J Ossmann; J N Katz
Journal:  Occup Environ Med       Date:  2005-11       Impact factor: 4.402

2.  The reliability and validity of the Turkish version of the Western Ontario Rotator Cuff Index.

Authors:  Ozlem El; Cigdem Bircan; Selmin Gulbahar; Yucel Demiral; Ebru Sahin; Meltem Baydar; Ramazan Kizil; Sharon Griffin; Elif Akalin
Journal:  Rheumatol Int       Date:  2006-06-24       Impact factor: 2.631

3.  Impact of distal median neuropathy on handwriting performance for patients with carpal tunnel syndrome in office and administrative support occupations.

Authors:  Li-Chieh Kuo; Hsiao-Man Hsu; Po-Ting Wu; Sheng-Che Lin; Hsiu-Yun Hsu; I-Ming Jou
Journal:  J Occup Rehabil       Date:  2014-06

4.  Predicting intentions to use research evidence for carpal tunnel syndrome treatment decisions among certified hand therapists.

Authors:  Gail N Groth
Journal:  J Occup Rehabil       Date:  2011-12

5.  A blinded placebo-controlled randomized trial on the use of astaxanthin as an adjunct to splinting in the treatment of carpal tunnel syndrome.

Authors:  Joy C Macdermid; Joshua I Vincent; Bing S Gan; Ruby Grewal
Journal:  Hand (N Y)       Date:  2011-12-30

Review 6.  Carpal Tunnel Syndrome and Other Entrapment Neuropathies.

Authors:  Kolawole Wasiu Wahab; Emmanuel O Sanya; Philip B Adebayo; Musbaudeen O Babalola; Hakeem G Ibraheem
Journal:  Oman Med J       Date:  2017-11

7.  Local steroid injection for moderately severe idiopathic carpal tunnel syndrome: protocol of a randomized double-blind placebo-controlled trial (NCT 00806871).

Authors:  Magnus Flondell; Manfred Hofer; Jonas Björk; Isam Atroshi
Journal:  BMC Musculoskelet Disord       Date:  2010-04-21       Impact factor: 2.362

8.  Assessing motor deficits in compressive neuropathy using quantitative electromyography.

Authors:  Joseph Nashed; Andrew Hamilton-Wright; Daniel W Stashuk; Matthew Faris; Linda McLean
Journal:  J Neuroeng Rehabil       Date:  2010-08-11       Impact factor: 4.262

9.  The 6-item CTS symptoms scale: a brief outcomes measure for carpal tunnel syndrome.

Authors:  Isam Atroshi; Per-Erik Lyrén; Christina Gummesson
Journal:  Qual Life Res       Date:  2009-02-20       Impact factor: 4.147

10.  Comparison of responsiveness of the Japanese Society for Surgery of the Hand version of the carpal tunnel syndrome instrument to surgical treatment with DASH, SF-36, and physical findings.

Authors:  S Uchiyama; T Imaeda; S Toh; K Kusunose; T Sawaizumi; T Wada; S Okinaga; J Nishida; S Omokawa
Journal:  J Orthop Sci       Date:  2007-05-31       Impact factor: 1.601

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.